Pharmacological and clinical evaluation of brigatinib——an anaplastic lymphoma kinase tyrosine kinase inhibitor

doi:10.3969/j.issn.1672-3384.2018.06.009

YANG Xue,NI Qian,PEI Yi-fang,FENG Yu-fei

Clinical Medication Journal ›› 2018, Vol. 16 ›› Issue (6) : 32-36.

PDF(920 KB)

Clinical Medication Journal ›› 2018, Vol. 16 ›› Issue (6) : 32-36. DOI: 10.3969/j.issn.1672-3384.2018.06.009

Pharmacological and clinical evaluation of brigatinib——an anaplastic lymphoma kinase tyrosine kinase inhibitor

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 16(6): 32-36 https://doi.org/10.3969/j.issn.1672-3384.2018.06.009

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(920 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2018-02-26	2018-06-30
Issue Date
2018-06-30

Please choose a citation manager

Content to export